Clinical Trials Directory

Trials / Completed

CompletedNCT05829720

Investigate Effects of A2 Milk on Breastmilk Composition and Subsequent Infant Gut Health, Crying and Sleep Patterns in Healthy, Full-term Infants

A Double-blind, Parallel Designed, Randomized Controlled Trial to Investigate Effects of Conventional Vs A2 Milk on Breastmilk Composition and Subsequent Infant Gut Health, Crying and Sleep Patterns in Healthy, Full-term Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
a2 Milk Company Ltd. · Industry
Sex
Female
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

The goal of this interventional study is to investigate effects of a2 Full Cream Milk on Breastmilk composition and subsequent Infant gut health, crying frequency and sleep patterns in Healthy Full-term Infants. 50 mothers and thier infants will be enrolled into 2 study sites, mother and her child as one subject will be randomized to 2 groups for assigned interventions, a2 Full Cream Milk and conventional Milk (Weidendorf). The study will continue for 14 days, and 3 site visits will be made duing the study period. All data specified in the protocol will be captured and recorded into CTMS for analysis. Researchers will compare the two groups of participants to see if a2 Full Cream Milk has significantly better breastmilk composition and improve infant's gut health, crying frequency and sleep patterns.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTa2 Full Cream MilkMothers in this arm will drink a2 Full Cream Milk twice a day, 200ml each time, for 14 consecutive days. Infants in this arm will be fed with mather's breastmilk exclusively.
DIETARY_SUPPLEMENTConventional Milk (Weidendorf)Mothers in this arm will drink Conventional Milk (Weidendorf) twice a day, 200ml each time, for 14 consecutive days. Infants in this arm will be fed with mather's breastmilk exclusively.

Timeline

Start date
2023-06-13
Primary completion
2023-08-17
Completion
2023-08-17
First posted
2023-04-26
Last updated
2024-11-04

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05829720. Inclusion in this directory is not an endorsement.